HomeNGEN • CVE
add
NervGen Pharma Corp
Previous close
$3.67
Day range
$3.57 - $3.67
Year range
$2.05 - $7.05
Market cap
267.46M CAD
Avg Volume
79.09K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.47M | 7.81% |
Net income | -9.10M | -16.33% |
Net profit margin | — | — |
Earnings per share | -0.13 | -18.18% |
EBITDA | -6.46M | -7.85% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.67M | -40.98% |
Total assets | 16.92M | -39.32% |
Total liabilities | 17.84M | 15.86% |
Total equity | -918.42K | — |
Shares outstanding | 73.28M | — |
Price to book | -367.00 | — |
Return on assets | -98.73% | — |
Return on capital | -5,297.20% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -9.10M | -16.33% |
Cash from operations | -3.67M | 12.33% |
Cash from investing | 25.23K | 199.98% |
Cash from financing | 4.75M | 4,170.82% |
Net change in cash | 1.20M | 132.14% |
Free cash flow | 1.51M | 1,350.88% |
About
Founded
2017
Headquarters
Website
Employees
10
